Overexpressed NF-κB-inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells

Blood

Volumn 111, Issue 10, 2008, Pages 5118-5129

  Saitoh, Yasunori ^a   Yamamoto, Norio ^a   Dewan, M Zahidunnabi ^a   Sugimoto, Haruyo ^a   Bruyn, Vicente J Martinez ^a   Iwasaki, Yuki ^a   Matsubara, Katsuyoshi ^a   Qi, Xiaohua ^a   Saitoh, Tatsuya ^b   Imoto, Issei ^c   Inazawa, Johji ^c   Utsunomiya, Atae ^d   Watanabe, Toshiki ^e   Masuda, Takao ^a   Yamamoto, Naoki ^a,f   Yamaoka, Shoji ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d Imamura Bun in Hospital   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RNA; VIRUS PROTEIN; NF KAPPA B KINASE; NF-KAPPA B KINASE; PROTEIN SERINE THREONINE KINASE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL TRANSFORMATION; CONTROLLED STUDY; DNA BINDING; FIBROBLAST; GENE CONTROL; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; REED STERNBERG CELL; REPRESSOR GENE; RNA INTERFERENCE; RNA TRANSLATION; SYSTEMATIC REVIEW; T CELL LEUKEMIA; ANIMAL; DRUG ANTAGONISM; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HODGKIN DISEASE; MOUSE; PATHOLOGY; PHYSIOLOGY; RAT; T CELL LEUKEMIA LYMPHOMA;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HODGKIN DISEASE; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MICE; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; RATS; REED-STERNBERG CELLS; RNA, SMALL INTERFERING;

EID: 46749111541     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-09-110635     Document Type: Article

References (53)

1. Baldwin AS Jr. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest. 2001;107:3-6.
2. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004;18:2195-2224.
3. Xiao G, Rabson AB, Young W, Qing G, Qu Z. Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease. Cytokine Growth Factor Rev. 2006;17:281-293.
4. Coope HJ, Atkinson PG, Huhse B, et al. CD40 regulates the processing of NF-kappaB2 p100 to pS2. EMBO J. 2002;21 :S375-538S.
5. Claudio E, Brown K, Park S, Wang H, Siebenlist U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol. 2002;3:958-965.
6. Karin M. Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2:301-310.
7. Jost PJ; Ruland J. Aberrant NF-{kappa}B signaling in lymphoma: mechanisms, consequences and therapeutic implications. Blood. 2006;109: 2700-2707.
8. Ni H, Ergin M, Huang Q, et al. Analysis of expression of nuclear factor kappa B (NF-kappa B) in multiple myeloma: downregulation of NF-kappa B induces apoptosis. Br J Haematol. 2001 ;115:279- 286.
9. Hironaka N, Mochida K, Mori N; Maeda M, Yamamoto N, Yamaoka S. Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells. Neoplasia. 2004;6:266-278.
10. Nonaka M, Horie R, Itoh K, Watanabe T, Yamamoto N, Yamaoka S. Aberrant NF-kappaB2/ p52 expression in Hodgkin/Reed-Sternberg cells and CD30-transformed rat fibroblasts. Oncogene. 2005;24:3976-3986.
11. Miura H, Maeda M, Yamamoto N, Yamaoka S. Distinct IkappaB kinase regulation in adult T cell leukemia and HTLV-l-transformed cells. Exp Cell Res. 2005:308:29-40.
12. Dejardin E, Bonizzi G, Bellahcene A, Castronovo V, Merville MP, Bours V. Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells. Oncogene. 1995: 11:1835-1841.
13. Lessard L Begin LR, Gleave ME, Mes-Masson AM. Saad F. Nuclear localization of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study. Br J Cancer. 2005:93:1019-1023.
14. Chandler NM. Canete JJ, Callery MP. Increased
15. expression of NF-kappa B subunits in human pancreatic cancer cells. J Surg Res. 2004;118:9- 14.
16. Bours V, Dejardin E, Goujon-Letawe R Merville MP, Castronovo V. The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines. Biochem Pharmacol. 1994;47:145-149.
17. Annunziata CM. Davis RE. Demchenko Y, et al. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell. 2007;12:115-130.
18. Keats JJ, Fonseca R, Chesi M, et al. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell. 2007;12:131-144.
19. Ramakrishnan P, Wang W, Wallach D. Receptor- specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF- kappaB-inducing kinase. Immunity. 2004;21:477- 489.
20. Liao G, Zhang M, Harhaj EW, Sun SC. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J Biol Chem. 2004;279: 26243-26250.
21. Qing G, Qu Z, Xiao G. Stabilization of basally translated NF-kappaB-inducing kinase (NIK) protein functions as a molecular switch of processing of NF-kappaB2 p100. J Biol Chem. 2005;280: 40578-40582.
22. Maeda M, Shimizu A, Ikuta K, et al. Origin of human T-lymphotrophic virus l-positive T cell lines in adult T cell leukemia: analysis of T cell receptor gene rearrangement. J Exp Med. 1985;162:2169- 2174.
23. + regulatory T cells. Int Immunol. 2004;16:1643-1656.
24. SugamuraK, Fujii M, Kannagi M, Sakitani M, Takeuchi M. Hinuma Y. Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Int J Cancer. 1984;34:221-228.
25. Foley GE. Lazarus H, Farber S, Uzman BG, Boone BG, McCarthy RE. Continuous cultured human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer. 1965;18:522- 529.
26. Weiss A, Wiskocil RL, Stobo JD. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL2 production reflects events occurring at pre-translational level. J Immunol. 1984:133:123-128.
27. Yamaoka S, Courtois G, Bessia C. et al. Complementation cloning of N EMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell. 1998;93:1231-1240.
28. Chinanonwait N, Miura H, Yamamoto N, Yamaoka S. A recessive mutant cell line with a constitutive IkappaB kinase activity. FEBS Lett. 2002;531:553-560.
29. Morita S, Kojima T, Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 2000;7:1063-1066.
30. Yamaoka S, Inoue H, Sakurai M, et al. Constitutive activation of NF-kappa B is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein. EMBO J. 1996;15:873-887.
31. Munoz E, Courtois G, Veschambre P, Jalinot P. Israel A. Tax induces nuclear translocation of NF- kappa B through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of I kappa B alpha/MAD3. J Virol. 1994;68:8035-8044.
32. null mice: suppression by an inhibitor against NF-κB. J Virol. 2003;77:5286-5294.
33. Krappmann D, Emmerich F, Kordes U, Schar- schmidt E, Dorken B, Scheidereit C. Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells. Oncogene. 1999;18:943-953.
34. Wood KM, Roff M. Hay RT. Defective IkappaBalpha in Hodgkin cell lines with constitutively active NF-kappaB. Oncogene. 1998;16:2131-2139.
35. Mori N, Fujii M, Ikeda S, et al. Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Blood. 1999;93:2360-2368.
36. Yemelyanov A, Gasparian A, Lindholm P, et al. Effects of IKK inhibitor PS1145 on NF-kappaB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells. Oncogene. 2006;25:387-398.
37. Farina AR, Tacconelli A, Vacca A, Maroder M, Gulino A, MackayAR. Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT- box and nuclear factor kappaB elements. Cell Growth Differ. 1999;10:353-367.
38. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 1995;9:899-909.
39. El-Sabban ME, Merhi RA. Haidar HA, et al. Human T-cell lymphotropic virus type 1 -transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells. Blood. 2002;99:3383-3389.
40. Mori N, Sato H, HayashibaraT, et al. Human T- cell leukemia virus type I Tax trans activates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness. Blood. 2002;99:1341-1349.
41. Hayashibara T, Yamada Y, Onimaru Y. et al. Matrix metalloproteinase-9 and vascular endothelial growth factor: a possible link in adult T-cell leukaemia cell invasion. Br J Haematol. 2002;116: 94-102.
42. Fukudome K, Furuse M, Fukuhara N, Orita T, Hinuma Y Strong induction of ICAM-1 in human T cells transformed by human T-cell leukemia virus type 1 and depression of ICAM-1 or LFA-1 in adult T-cell leukemia-derived cell lines. Int J Cancer. 1992;52:418-427.
43. Mori N, Yamada Y, IkedaS, et al. Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-1-infected T-cell lines and primary adult T-cell leukemia cells. Blood. 2002;100:1828-1834.
44. Bargou RC, Emmerich F, Krappmann D. et al. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest. 1997;100:2961-2969.
45. Yang J, Amiri Kl, Burke JR; Schmid JA, Richmond A. BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways. Clin Cancer Res. 2006;12: 950-960.
46. Gasparian AV; Yao YJ, Kowalczyk D, et al. The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells. J Cell Sci. 2002;115:141-151.
47. Wang CY Cusack JC Jr, Liu R, Baldwin AS Jr. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med. 1999;5:412- 417.
48. Gilmore TD, Herscovitch M. Inhibitors of NF-kappaB signaling: 785 and counting. Oncogene. 2006;25:6887-6899.
49. Braun T Carvalho G. Fabre C, Grosjean J. Fenaux P. Kroemer G. Targeting NF-kappaB in hematologic malignancies. Cell Death Differ. 2006; 13:748-758.
50. Courtois G, Gilmore TD. Mutations in the NF-kappaB signaling pathway: implications for human disease. Oncogene. 2006;25:6831-6843.
51. Sun SC, Yamaoka S. Activation of NF-kappaB by HTLV-I and implications for cell transformation. Oncogene. 2005;24:5952-5964.
52. Liptay S, Schmid RM. Nabel EG, Nabel GJ. Transcriptional regulation of NF-kappa B2: evidence for kappa B-mediated positive and negative auto- regulation. Mol Cell Biol. 1994;14:7695-7703.
53. Bren GD, Solan NJ, Miyoshi H, Pennington KN, Pobst LJ, Paya GV. Transcription of the RelB gene is regulated by NF-kappaB. Oncogene. 2001;20:7722-7733.